92 related articles for article (PubMed ID: 18191638)
1. Expression of Kir 4.1 in human astrocytic tumors: correlation with pathologic grade.
Tan G; Sun SQ; Yuan DL
Biochem Biophys Res Commun; 2008 Mar; 367(4):743-7. PubMed ID: 18191638
[TBL] [Abstract][Full Text] [Related]
2. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
[TBL] [Abstract][Full Text] [Related]
3. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
[TBL] [Abstract][Full Text] [Related]
5. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
[TBL] [Abstract][Full Text] [Related]
6. Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry.
Cao L; Cao W; Zhang W; Lin H; Yang X; Zhen H; Cheng J; Dong W; Huo J; Zhang X
Neurosci Lett; 2008 Feb; 432(2):94-9. PubMed ID: 18242847
[TBL] [Abstract][Full Text] [Related]
7. Proliferative gliosis causes mislocation and inactivation of inwardly rectifying K(+) (Kir) channels in rabbit retinal glial cells.
Ulbricht E; Pannicke T; Hollborn M; Raap M; Goczalik I; Iandiev I; Härtig W; Uhlmann S; Wiedemann P; Reichenbach A; Bringmann A; Francke M
Exp Eye Res; 2008 Feb; 86(2):305-13. PubMed ID: 18078934
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors.
Mennel HD; Lell B
Clin Neuropathol; 2005; 24(1):13-8. PubMed ID: 15696779
[TBL] [Abstract][Full Text] [Related]
10. Expression of EphA2 in human astrocytic tumors: correlation with pathologic grade, proliferation and apoptosis.
Li X; Wang Y; Wang Y; Zhen H; Yang H; Fei Z; Zhang J; Liu W; Wang Y; Zhang X
Tumour Biol; 2007; 28(3):165-72. PubMed ID: 17519535
[TBL] [Abstract][Full Text] [Related]
11. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
[TBL] [Abstract][Full Text] [Related]
12. Expression in childhood primary brain tumors of NY-ESO-1, a cancer/testis antigen: an immunohistochemical study.
Bodey B; Bodey V; Siegel SE
In Vivo; 2008; 22(1):83-7. PubMed ID: 18396787
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of the expression of the RCAS1 mRNA and protein in astrocytic tumors].
Shen CF; Yuan XR; Qin ZQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):836-9. PubMed ID: 18007080
[TBL] [Abstract][Full Text] [Related]
14. Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors.
Nakagawa T; Kabuto M; Kubota T; Kodera T; Sato K
Anticancer Res; 1999; 19(4B):2963-8. PubMed ID: 10652580
[TBL] [Abstract][Full Text] [Related]
15. Podocalyxin expression in malignant astrocytic tumors.
Hayatsu N; Kaneko MK; Mishima K; Nishikawa R; Matsutani M; Price JE; Kato Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):394-8. PubMed ID: 18639524
[TBL] [Abstract][Full Text] [Related]
16. Study of correlation between expression of bradykinin B2 receptor and pathological grade in human gliomas.
Zhao Y; Xue Y; Liu Y; Fu W; Jiang N; An P; Wang P; Yang Z; Wang Y
Br J Neurosurg; 2005 Aug; 19(4):322-6. PubMed ID: 16455538
[TBL] [Abstract][Full Text] [Related]
17. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
[TBL] [Abstract][Full Text] [Related]
18. Distinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumors.
Ellert-Miklaszewska A; Grajkowska W; Gabrusiewicz K; Kaminska B; Konarska L
Brain Res; 2007 Mar; 1137(1):161-9. PubMed ID: 17239827
[TBL] [Abstract][Full Text] [Related]
19. RhoA protein expression correlates positively with degree of malignancy in astrocytomas.
Yan B; Chour HH; Peh BK; Lim C; Salto-Tellez M
Neurosci Lett; 2006 Oct; 407(2):124-6. PubMed ID: 16978776
[TBL] [Abstract][Full Text] [Related]
20. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors.
Blümcke I; Müller S; Buslei R; Riederer BM; Wiestler OD
Acta Neuropathol; 2004 Aug; 108(2):89-96. PubMed ID: 15146346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
